EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Spatial patterns of amyloid clearance after donanemab: A preliminary 12‐month real‐world amyloid PET study in Japanese patients with early Alzheimer's disease

Yuki Kujuro iD, Marina Saito, Manami Maruko, Emi Qian, Hidefumi Koh, Hitoshi Katai, Hidenori Hattori

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-10 · 18 (4)

DOI: 10.1002/dad2.70539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 30.10.2026. Verfasst von Yuki Kujuro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Tachikawa Hospital Tokyo Japan. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The regional pattern of amyloid clearance during donanemab treatment in routine practice is poorly characterized.

Methods

We analyzed amyloid positron emission tomography (Centiloid, regional standardized uptake value ratio, visual reads) at baseline and 12 months in 18 donanemab‐treated patients with early Alzheimer's disease.

Results

Clearance was near‐complete (removal 96%; 72% visually negative, i.e., full treatment‐related amyloid clearance), although lower in the 2 early‐onset (78%) than the 16 late‐onset patients (98%). Higher baseline burden and older age predicted greater clearance ( r = 0.88, P < .001; r = 0.60, P = .009, respectively). This held regionally ( r = 0.82–0.91, all P < .001), with the posterior cingulate and precuneus clearing first. Clearance was independent of medial temporal atrophy and unrelated to 12‐month cognitive change.

Discussion

Donanemab cleared regional amyloid in proportion to its baseline distribution, with deposition‐heavy regions clearing first and the temporal cortex retaining residual signal, independent of neurodegenerative stage and unrelated to short‐term cognition.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseCentiloidamyloid positron emission tomographyanti‐amyloid therapydonanemabreal‐world evidenceregional amyloid clearancespatial clearance patternstriatum

Autor:innen und Institutionen

  • Department of Neurology Tachikawa Hospital Tokyo Japan.
  • Department of Neurology Keio University School of Medicine Tokyo Japan.
  • Department of Pulmonary Medicine Tachikawa Hospital Tokyo Japan.
  • Department of Gastroenterological Surgery Tachikawa Hospital Tokyo Japan.

ORCID-Profile: Yuki Kujuro

Zitieren

APA

Kujuro, Y., Saito, M., Maruko, M., Qian, E., Koh, H., Katai, H., & Hattori, H. (2026). Spatial patterns of amyloid clearance after donanemab: A preliminary 12‐month real‐world amyloid PET study in Japanese patients with early Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(4). https://doi.org/10.1002/dad2.70539

Vancouver

Kujuro Y, Saito M, Maruko M, Qian E, Koh H, Katai H, et al. Spatial patterns of amyloid clearance after donanemab: A preliminary 12‐month real‐world amyloid PET study in Japanese patients with early Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(4). doi:10.1002/dad2.70539

BibTeX
@article{Kujuro2026,
  author = {Kujuro, Yuki and Saito, Marina and Maruko, Manami and Qian, Emi and Koh, Hidefumi and Katai, Hitoshi and Hattori, Hidenori},
  title = {Spatial patterns of amyloid clearance after donanemab: A preliminary 12‐month real‐world amyloid PET study in Japanese patients with early Alzheimer's disease},
  journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
  year = {2026},
  volume = {18},
  number = {4},
  doi = {10.1002/dad2.70539}
}
Kostenlos starten →